First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer in the Phase III EXCLAIM-2 Trial.
Jänne PA, Wang BC, Cho BC, Zhao J, Li J, Hochmair M, Peters S, Besse B, Pavlakis N, Neal JW, Kato T, Wu YL, Nguyen D, Lin J, Lin J, Vranceanu F, Szumski A, Lin HM, Fram RJ, Mok TSK.
Jänne PA, et al. Among authors: wang bc.
J Clin Oncol. 2025 Jan 29:JCO2401269. doi: 10.1200/JCO-24-01269. Online ahead of print.
J Clin Oncol. 2025.
PMID: 39879577